Claim Details

View detailed information about this claim and its related sources.

Back to Claims

Claim Information

Complete details about this extracted claim.

Claim Text
One in 4 Medicare beneficiaries who are overweight or obese might be eligible for coverage of Wegovy now that it’s approved to reduce heart attack and stroke risk, according to a KFF analysis out today.
Simplified Text
One in 4 Medicare beneficiaries overweight or obese might be eligible for Wegovy coverage
Confidence Score
0.950
Claim Maker
The author
Context Type
News Article
Context Details
{
    "drug": "Wegovy",
    "event": "Approved to reduce heart attack and stroke risk",
    "organization": "KFF"
}
Subject Tags
Health Statistical
UUID
a1165f6b-a2d1-4e00-ac8c-38d9bfc446a0
Vector Index
âś— No vector
Created
February 15, 2026 at 4:57 PM (6 months ago)
Last Updated
February 15, 2026 at 4:57 PM (6 months ago)

Original Sources for this Claim (1)

All source submissions that originally contained this claim.

Screenshot of https://www.politico.com/newsletters/politico-pulse/2024/04/24/pharma-lobbying-up-in-2024-00153996
Pharma lobbying up in 2024
Completed News
21 claims 🔥
1 week ago
https://www.politico.com/newsletters/politico-pulse/2024/04/24/pharma-lobbying-up-in-2024-00153996

Pharmaceutical companies increased lobbying spending in the first quarter of 2024. Key issues driving the spending include 340B program reform, supply chain issues, and pharmacy benefit manager regulations. The article also covers Supreme Court arguments on abortion and bird flu fragments in milk.

Pharmaceuticals Lobbying Healthcare Policy Abortion Bird Flu Medicare Supreme Court

Similar Claims (5)

Other claims identified as semantically similar to this one.